Stay updated on Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Sign up to get notified when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.

Latest updates to the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page
- Check2 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedA new Sample Collection item was added to the study plan, clarifying biospecimen collection procedures. The protocol revision was updated from v3.5.3 to v3.5.4, replacing the previous version.SummaryDifference0.2%

- Check24 days agoNo Change Detected
- Check38 days agoChange DetectedThe page revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a maintenance or software release without changing the underlying study content.SummaryDifference0.0%

- Check46 days agoChange DetectedRevision updated from v3.5.0 (2026-04-08) to v3.5.2 (2026-04-13).SummaryDifference0.2%

- Check53 days agoChange DetectedAdded update dates 2026-04-08 and 2026-04-09, and removed 2026-04-01 and 2026-04-02 from the study record history; these are maintenance edits that do not modify the trial details or outcomes.SummaryDifference0.1%

- Check60 days agoChange DetectedThe update history shows additions for 2026-04-02 and 2026-04-01 and deletions for 2026-03-25 and 2026-03-24.SummaryDifference0.1%

- Check67 days agoChange DetectedAdministrative updates were made to the study record, adding update dates of 2026-03-24 and 2026-03-25 and removing 2026-03-18 and 2026-03-19. These changes do not alter the study’s core content, eligibility, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Testing KRT-232 Combo with Decitabine & Venetoclax in AML Clinical Trial page.